Bionano Genomics (BNGO) Gross Margin (2017 - 2026)

Bionano Genomics has disclosed Gross Margin across 10 years of filings, most recently posting 48.63% for Q1 2026.

• Gross Margin for Q1 2026 came in at 48.63%, up 313.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 46.97% (up 2911.0% YoY), and the FY2025 annual result was 46.25%, up 4502.0% from the prior year.
• Gross Margin came in at 48.63% for Q1 2026 at Bionano Genomics, up from 42.75% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 98.08% in Q4 2024 to a low of 139.07% in Q3 2024.
• The 5-year median for Gross Margin is 29.5% (2023), against an average of 26.46%.
• Across the five-year window, Gross Margin sank 16858 bps in 2024 and jumped 18482 bps in 2025, its largest moves.
• Bionano Genomics' Gross Margin stood at 21.97% in 2022, then advanced by 3 bps to 22.74% in 2023, then soared by 331 bps to 98.08% in 2024, then tumbled by 56 bps to 42.75% in 2025, then advanced by 14 bps to 48.63% in 2026.
• The last three Gross Margin figures came in at 48.63% (Q1 2026), 42.75% (Q4 2025), and 45.74% (Q3 2025), per Business Quant data.